INTERNATIONAL JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2021-09-04 凶巴巴恰北北怪兽

7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好

102 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2020-04-15 兮牧歌

据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表::
under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表:
under review是送审的意思吗？你的结果有回来吗？

cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？

135 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2021-11-16 hydrablue

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;手术;标志物
经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。

93 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2021-11-26 Jack Sand暂无昵称

偏重的研究方向：肿瘤研究;标志物
经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息

53 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2020-07-29 ZM2222

7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？

237 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2020-07-02 碧雪凝冰

六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天

156 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2020-09-04 Nevermorx

有没有人投综述呀

152 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2021-11-01 ms9000000340869620

10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2020-06-29 mswert122

5.145分，今年

137 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1014443, encodeId=0aad1014443bf, content=7.14投稿 8.20一审回来，大修 8.24修回，当天外审 8.30under evaluation 9.1awaiting 9.3接收编辑很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sat Sep 04 01:30:04 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588956, encodeId=dfdc588956b5, content=据说超过一周就有可能是送审了，我的已经回来了，一审一个月左右cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？cxw1008 2020-04-14 00:00:00 发表: under review是送审的意思吗？你的结果有回来吗？, beContent=cxw1008 2020-04-14 发表:: under review是送审的意思吗？你的结果有回来吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070833, encodeId=349810e0833cc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;手术;标志物 经验分享：8-26投稿，9月初跟我说准备送审，改格式，9-17重新提交，现在还在under review。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e411946780, createdName=hydrablue, createdTime=Tue Nov 16 18:09:12 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074107, encodeId=a9fb10e41076e, content=偏重的研究方向：肿瘤研究;标志物 经验分享：请问各位大佬，这个杂志underevaluation是不是持续越久越易拒稿啊？我这个状态21号开始持续了5天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10f62281888, createdName=Jack Sand暂无昵称, createdTime=Fri Nov 26 10:25:04 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805070, encodeId=996c8050e006, content=7月15号投稿，至今一直是under evaluation 是什么情况？需要写邮件催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaMia0X5uB8LDpcIg1dNfR0XqgBDibRZGe52oTDiaCJUJKZS5TcZQNcLLn9OwnKSMYxANon5ibXWQN3ibWXicick1A3Z5Q/132, createdBy=ba025260217, createdName=ZM2222, createdTime=Wed Jul 29 15:36:25 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800846, encodeId=484f800846c3, content=六月九号提交，三天initial Q,之后变成under review,四五天后变成evaluation,再过四五天后又变成under review直到今天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/b3be00fb2b6b622306fe07fd2356b7ac.jpg, createdBy=fb132163002, createdName=碧雪凝冰, createdTime=Thu Jul 02 01:09:52 CST 2020, time=2020-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882727, encodeId=42e4882e2702, content=有没有人投综述呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200927/261b1f9f20d24144bab68b2430f4b774/baaa7e0ae3234a32b652d4b1fd1aa53f.jpg, createdBy=afc55408430, createdName=Nevermorx, createdTime=Fri Sep 04 17:23:50 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065709, encodeId=7b951065e09a4, content=10-21投稿under evaluation，11-1直接变成waiting decision，请问大家，是不是没戏了啊TAT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55ce5502582, createdName=ms9000000340869620, createdTime=Mon Nov 01 09:17:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800410, encodeId=f7c88004105e, content=5.145分，今年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Mon Jun 29 21:33:51 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564716, encodeId=8f58564e16aa, content=投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f28b1615792, createdName=bicia, createdTime=Fri Dec 21 00:00:00 CST 2018, time=2018-12-21, status=1, ipAttribution=)]

2018-12-21 bicia

投了第二天就awaiting decision,4天了也不给结果，要拒就快点拒啊，耽误时间的说

149 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务